Background/Goals: The endoscopic treatment of ampullary adenomas is established; however, the false-negative rate of endoscopic biopsy for carcinoma is 20% to 30%, and it remains uncertain whether identifiable features predict malignancy. Our aim in this study was to evaluate the predictable factors of malignancy in ampullary adenomas on endoscopic biopsy.
C omplete removal is essential to cure ampullary adenomas, because of their malignant potential. Endoscopic papillectomy has been recognized as a safe and reliable treatment modality for ampullary adenomas. 1 It is commonly agreed that the indication for endoscopic papillectomy is an adenoma of the papilla of Vater that, is confined to the ampullary region. 2 Several studies have reported that the endoscopic resection of ampullary adenomas was successful in 75% to 90% of subjects with a 15% to 20% recurrence rate and a 20% to 27% complication rate. 3, 4 There appears to be an adenoma to carcinoma progression sequence in ampullary adenomas but the time frame for malignant transformation is variable and some lesions have been followed for years without significant progression. 5 Because of its malignant potential, complete removal of adenoma is essential for curative therapy. 6 Endoscopic papillectomy has been established as a safe and reliable treatment modality for benign tumors of the ampulla. 3 However, false-negative rates of endoscopic mucosal biopsies have been reported between 20% and 30%. 7, 8 Several studies have addressed the problem of the low diagnostic accuracy of endoscopic forceps biopsies in differentiating between benign adenomas and carcinomas. The prediction of malignancy would be helpful for planning therapeutic regimens. However, the risk factors for prediction of carcinoma in ampullary adenomas are not yet known. The aim of this study was to evaluate the predictors of malignancy in ampullary adenomas on endoscopic biopsy.
MATERIALS AND METHODS

Study Sample and Evaluation of Endoscopic Features
This study was conducted at the Samsung Medical Center, Seoul, Korea. We retrospectively identified all subjects with ampullary adenomas by performing a search in our pathology database for cases of ampullary adenoma on endoscopic biopsy between January 1995 and March 2011. The study protocol was approved by the Institutional Review Board of Samsung Medical Center. Exclusion criteria included subjects who underwent no curative treatments such as endoscopic papillectomy or surgical resection.
Baseline characteristics and endoscopic findings were assessed. The following parameters were recorded and analyzed: subject age, sex, presence of symptoms, tissue type, degrees of dysplasia on endoscopic biopsy, papilla enlargement on computed tomography (CT), and ductal dilatation on any images. Symptoms were classified according to 3 definitions: acute cholangitis, defined as a fever, abdominal pain, and elevated serum hepatobiliary enzyme levels; acute pancreatitis, defined as abdominal pain, and elevated serum amylase levels to >3 times the upper reference limit; and biliary pain, defined as an episode of steady, moderate to severe pain located in the epigastrium or right upper abdominal quadrant lasting Z30 minutes and, not relieved by bowel movements, postural changes, or antacids. The presence of symptoms was defined by the presence of at least one of 2 symptom complexes. On the basis of the pathology of the endoscopic biopsy, subjects were categorized as having villous components or not. Papilla enlargement was defined as Z1 cm in size on CT. Ductal dilatation was defined as measuring >7 mm in diameter at the pancreatic head on CT scans, endoscopic retrograde cholangiopancreatography, or endoscopic ultrasound (EUS), and was categorized as absent and present by 2 independent observers. 9 Seventy-six patients (83.5%) were given CT scan before endoscopic papillectomy or surgical resection. Each endoscopic report was reviewed to determine the macroscopic appearance of the lesion. All endoscopies were reviewed in standardized manner by 2 endoscopists (H.N.K., J.K.L.) before the pathologic data were merged with the endoscopic results.
The surface configuration (granularity, nodularity, or erosion), color (normal, pale, hyperemia, or easy touch bleeding), presence of duodenal extension, and exposure of tumor were also evaluated. Surface granularity was defined as consistence of or appearance to consist of even granules. Nodularity was defined as the presence of irregularly raised or nodular mucosa. Surface color was defined as a whitish or red discoloration on the mucosal surface of the lesion compared with the surrounding mucosa.
Histologic Examination
Histologic sections were stained with hematoxylin eosin and Wright-Giemsa stain and examined by a single experienced pathologist (K.M.K.), who performed diagnoses according to the Vienna classification of gastrointestinal epithelial neoplasia (Table 1) . Specimens obtained by forceps biopsy and after endoscopic or surgical resection were evaluated by the same pathologist.
Statistical Analysis
Baseline characteristics were compared using the w 2 test or Fisher exact test. These statistical analyses were performed with PASW Statistics 17.0 (SPSS Inc., Chicago, IL). A generalized estimating equation logistic regression model was used to identify risk factors for high-grade dysplasia (HGD) or carcinoma while adjusting for the correlation among Z2 lesions from the same subjects. Multivariate logistic regression analysis, corrected for baseline univariate risk factors was used to evaluate predictive factors for adenocarcinoma. The sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs), and diagnostic accuracy were all calculated with 95% confidence intervals. P values <0.05 were regarded as statistically significant.
RESULTS
Ninety-two subjects with ampullary adenomas on endoscopic biopsy were identified. We excluded 1 subject who underwent endoscopic surveillance without treatment (n = 1). Endoscopic resection was performed in 57 subjects and surgical resection was performed in the remaining 34 subjects. The reasons for surgical resection were endoscopic impression of malignancy with HGD on endoscopic biopsy, a lateral spreading tumor on endoscopic view, an enlarged mass >4 cm, and suspicious ductal involvement at EUS. The mean number of forceps biopsies performed ( ± SD) was 3.3 ( ± 1.65) for each lesion. Table 2 shows the distribution of the final pathologic diagnoses based on the Vienna classification ( Table 1 ). The final histopathologic diagnoses of the ampullary tumor were 49 low-grade adenoma (53.8%), 18 high-grade adenoma (19.8%), 4 carcinoma in situ (Cis) (4.4%), and 20 adenocarcinoma (22%). There was agreement of 53.8% (48/91) between the histologic diagnoses based on forceps biopsy and the postresection results. An upgrade of the diagnosis to Cis (category 4.2) or carcinoma (category 5) was made for 24 lesions (26.4%) and a downgrade of the diagnosis from HGD to "low-grade dysplasia (LGD)" was made for 6 lesions (6.5%). The carcinomas were characterized as "well," "moderately," and "poorly-differentiated" adenocarcinoma in 19 (79%), 1 (4%), and 3 (12.5%) of cases, respectively. One subject had adenosquamous carcinoma. Four of the carcinoma patients had Cis, 15 had T1 cancer limited to the major papilla, and 5 had invasion of the duodenal muscularis propria. There were no subjects with tumors that invaded the pancreas or metastasized to the lymph node.
Histology of Resected Specimens
Analysis of Predictive Factors of Malignancy After Resection of Ampullary Tumor
We compared the baseline characteristics, radiologic findings, laboratory findings, and endoscopic findings between the final adenoma and carcinoma groups. The presence of symptoms, age older than 65 years, papilla enlargement on CT scan, ductal dilatation, villous component, HGD, total bilirubin > 2 mg/dL, aspartate aminotransferase > 40 IU/L, alanine aminotransferase > 40 IU/L, and alkaline phosphatase > 90 IU/L were significantly different between the 2 groups (Table 3 ). Multivariate analysis showed that the degree of dysplasia and presence of ductal dilatation were associated with upgrades of the diagnosis to Cis/carcinoma (Table 4) .
Sensitivity, Specificity, Accuracy, and PPVs and NPVs of Malignancy
The presence of Z1 risk factors in a lesion (low cut-off value) had high sensitivity (95.8%) and NPV (96.8%) for malignancy (Table 5) . Therefore, when an ampullary adenoma did not include any of the risk factors, it was less likely to be upgraded to Cis or carcinoma. In contrast, the presence of 2 risk factors (high cut-off value) resulted in a high specificity (96.1%) and PPV (84.6%). Thus, diagnosis is likely to be upgraded to Cis or carcinoma when 2 risk factors were present.
Management Outcomes of Ampullary Adenomas
The complete resection rate was 87.7% and 97% in subjects with endoscopic papillectomy and surgical resection, respectively. The rates of incomplete resection were 12.2% and 2.9% in endoscopic papillectomy and surgical resection, respectively. All 7 subjects with remnant adenoma after endoscopic papillectomy underwent additional surgical resection. One subject with a positive surgical margin after initial surgical ampullectomy underwent additional pylorus-preserving pancreaticoduodenectomy (Fig. 1) .
Sixteen subjects experienced complications after endoscopic papillectomy. Postpapillectomy bleeding occurred in 8 subjects and was successfully managed using endoscopic hemostatic techniques (electric coagulation or hemoclip). Eight cases (14%) of postpapillectomy pancreatitis were mild and responded to conservative management. Endoscopic papillectomy complicated by a small retroperitoneal perforation occurred in 1 subject (1.7%) who recovered completely after medical treatment.
During the follow-up period, after the endoscopic or surgical resection (mean follow-up ± SD, 26.6 ± 24.7 mo; median, 16 mo), 6 subjects were diagnosed with a local recurrence. All the 6 subjects were found to have LGD (Vienna category 3.0). Additional surgical resection (2 subjects), endoscopic resection (1 subjects), hot biopsy (2 subjects), and follow-up (1 subject) were performed for the management of recurrent adenomas.
DISCUSSION
Complete removal is essential to cure ampullary adenomas, because of their malignant potential. Endoscopic papillectomy has been recognized as a safe and reliable treatment modality for ampullary adenomas. 1 It is commonly agreed that the indication for endoscopic papillectomy is an adenoma of the papilla of Vater that is confined to the ampullary region. 2 Several studies have reported that the endoscopic resection of ampullary adenomas was successful in 75% to 90% of subjects with a 15% to 20% recurrence rate and a 20% to 27% complication rate. 3, 4 Pancreaticoduodenectomy is considered the standard treatment for ampullary cancer. However, some reports have suggested endoscopic treatment as an alternative to surgery for selected ampullary cancer patients. 6 In place of surgical resection, endoscopic papillectomy is now being considered as the curative therapy for patients with ampullary adenoma that contains HGD/Cis, although data to support such approach is insufficient. 10 For an ampullary adenoma that contains focal T1 cancer, however, there have been only anecdotal reports of endoscopic papillectomy, and radical surgery is still recommended as the definitive approach for achieving curative resection. Therapeutic indications for endoscopic papillectomy of an ampullary adenoma have not been established because it is difficult to predict a presence of carcinoma inside ampullary adenoma. A biopsy performed during endoscopy is the best method by which to obtain accurate diagnostic information, but it can occasionally be difficult to rule out malignancy in an adenoma because the histopathology of the lesion is not homogeneous. 11 Therefore, an initial finding in an adenoma cannot exclude the presence of a focus of carcinoma in an unsampled part of the lesion. False-negative rates of endoscopic mucosal biopsies have been reported between 20% and 30%. 7, 8 In our study, the discrepancy between pretreatment histology and postendoscopic resection results was 26%. This large difference may have resulted from the small number of biopsy sample. It is also difficult to detect carcinoma by forcep biopsy especially when it is located in the unexposed area. There are complications such as pancreatitis in partaking forcep biopsy on the ampulla of Vater. To reduce complications, we recommend getting 4 more biopsy samples excluding orifice area.
The factors predictive of malignancy in ampullary adenomas proven by endoscopic biopsy have not been reported. Kahaleh et al 12 demonstrated that failure to achieve a cleavage plane with submucosal injection appears to be the strongest predictor of malignancy. In the present study, we observed a correlation between the probability that a diagnosis would be upgraded to Cis/carcinoma and the presence of ductal dilatation or a high grade of dysplasia.
When Z1 risk factors (low cut-off value) were present in an ampullary adenoma lesion, we found a high sensitivity (95.8%, 23/24) and NPV (96.7%, 30/31) for Cis or carcinoma. This result suggests that a papillary adenoma lesion with no risk factors is less likely to be upgraded to Cis or carcinoma. Furthermore, of the 31 cases without any of the 2 risk factors, 30 (true negative portion) lesions were adenoma (NPV, 30/31), whereas 1 lesion (false-negative portion) was proven to be carcinoma, limited to the ampulla of Vater, in the final pathologic diagnosis. Therefore, an adenoma without any of the 2 risk factors is much less likely to have invasive carcinoma.
In addition, a lesion that has a single risk factor is likely to be Cis or carcinoma, and thus additional study can be considered. EUS is an important diagnostic tool in the evaluation of ampullary lesions as it increases the diagnostic yield of endoscopic biopsies and helps determine the optimal approach to resection. The detection rate of ampullary carcinoma improves to >90% when endoscopic biopsies are combined with EUS ± fine needle aspiration. 13, 14 EUS is useful for distinguishing a benign, protuberant ampulla from an ampullary carcinoma when evidence of tumor invasion is observed, defined as infiltration of the duodenal muscularis propria, common bile duct or Wirsung duct. 2 However, it would be complicated to distinguish ampullary carcinoma without tumor invasion, such as Cis, from ampullary adenoma.
Endoscopic findings of a reddish nodular tumor associated with erosion and easy bleeding indicate malignancy. Ulceration or fold convergence of the neighboring duodenum suggests tumor invasion into the duodenal wall or pancreatic parenchyma. 15 However, in our study, there were no significant differences in endoscopic findings between the 2 groups, probably because all subjects had focal or early-stage carcinoma <T2.
Previous reports have strongly suggested that highgrade adenoma/dysplasia (HGD, category 4 in the Vienna classification) is highly predictive of invasive carcinoma in gastric cancer. In accordance with previous studies of gastric cancer, subjects with HGD in an ampullary adenoma were at a higher risk for malignancy. 16 The strengths of our study include the use of the Vienna classification system for microscopic assessment, which reduced the possibility of interobserver variation. Our sample size was sufficiently large to permit multivariate analysis. In addition, we minimized the possibility of selection bias by performing endoscopic or surgical resection on almost all ampullary adenoma lesions, regardless of size. However, this study has important limitations, mostly stemming from restrospective design. Treatment decisions, either endoscopic or surgical, are not made randomly and diagnostic tests were not identical. Therefore, our recommendations based on the comparison of both types of treatment are not absolute.
Precautions should be taken in the management of patients with ampullary adenoma, especially when risk factors including ductal dilatation or HGD are present. Because complication rates of endoscopic papillectomy are reported up to 25% and additional surgery is needed when carcinoma revealed. Therefore, when a lesion has neither of the 2 risk factors, endoscopic resection rather than surgical resection is recommended. However, surgical resection is strongly recommended when a lesion has 2 risk factors even though the result of the endoscopic biopsy revealed benign. If the ampullary adenoma has 1 risk factor, additional study using EUS, intraductal ultrasonography, or careful endoscopic papillectomy can be considered for diagnostic and therapeutic purpose.
